Integrated Diagnostics Holdings Plc (IDHC) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.82 M

Shareholding (Jun 2022)

FII

0.03%

Held by 1 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

USD 395 Million ()

P/E

15.00

Industry P/E

Dividend Yield

1.52%

Debt Equity

-0.66

Return on Equity

38.83%

Price to Book

7.41

Revenue and Profits:

Net Sales:

33 Million

(Quarterly Results - Sep 2024)

Net Profit:

5 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

8.93%

6 Months

76.81%

1 Year

38.01%

2 Years

88.27%

3 Years

-10.29%

4 Years

-53.52%

5 Years

-34.05%

Integrated Diagnostics Holdings Plc for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-28.57%

EBIT Growth (5y)

-35.43%

EBIT to Interest (avg)

7.26

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.46

Sales to Capital Employed (avg)

2.04

Tax Ratio

32.26%

Dividend Payout Ratio

42.50%

Pledged Shares

Institutional Holding

0.03%

ROCE (avg)

111.04%

ROE (avg)

25.77%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.81

EV to EBIT

9.42

EV to EBITDA

7.24

EV to Capital Employed

9.93

EV to Sales

2.22

PEG Ratio

1.02

Dividend Yield

1.94%

ROCE (Latest)

105.32%

ROE (Latest)

38.83%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2022

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is -13.09% vs -13.57% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is -12.28% vs 400.00% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33.20",
          "val2": "38.20",
          "chgp": "-13.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.30",
          "val2": "12.60",
          "chgp": "5.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "1.30",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.00",
          "val2": "5.70",
          "chgp": "-12.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "401.50%",
          "val2": "246.70%",
          "chgp": "15.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.04% vs -28.43% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 45.10% vs -44.16% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "126.10",
          "val2": "134.20",
          "chgp": "-6.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "36.40",
          "val2": "37.10",
          "chgp": "-1.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.30",
          "val2": "5.20",
          "chgp": "-17.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "-0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "22.20",
          "val2": "15.30",
          "chgp": "45.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "203.90%",
          "val2": "179.20%",
          "chgp": "2.47%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY

Sep'24

Sep'23

Change(%)

Net Sales

33.20

38.20

-13.09%

Operating Profit (PBDIT) excl Other Income

13.30

12.60

5.56%

Interest

0.00

1.30

-100.00%

Exceptional Items

0.00

Consolidate Net Profit

5.00

5.70

-12.28%

Operating Profit Margin (Excl OI)

401.50%

246.70%

15.48%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2024 is -13.09% vs -13.57% in Sep 2023

Consolidated Net Profit

YoY Growth in quarter ended Sep 2024 is -12.28% vs 400.00% in Sep 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

126.10

134.20

-6.04%

Operating Profit (PBDIT) excl Other Income

36.40

37.10

-1.89%

Interest

4.30

5.20

-17.31%

Exceptional Items

-0.70

Consolidate Net Profit

22.20

15.30

45.10%

Operating Profit Margin (Excl OI)

203.90%

179.20%

2.47%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -6.04% vs -28.43% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 45.10% vs -44.16% in Dec 2023

All Annual Results

Company CV

About Integrated Diagnostics Holdings Plc

Integrated Diagnostics Holdings Plc

Hospital

Integrated Diagnostics Holdings plc is an integrated diagnostics services provider in Egypt. The Company operates in three geographic areas: Egypt, Sudan and Jordan. The Company provides over 1,000 diagnostic services ranging from basic tests to molecular tests for hepatitis and specialized deoxyribonucleic acid (DNA) tests to patients, and operates approximately 310 branches. The Company offers a range of services, such as Immunology, Radiology, Hematology, Endocrinology, Molecular Biology, Cytogenetics, Hatopathology and Microbiology. The Company's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan, and Ultralab and Al Mokhtabar Sudan in Sudan. The Company also operates the Medical Genetics Centre brand in Egypt. Its Al Mokhtabar medical testing and diagnostic center provides services, including radiological tests, a center for allergy, a unit for nutritional advice, pre-employments tests, medical examination in different fields and checkup packages.

Company Coordinates

Company Details

12 Castle Street , SAINT HELIER None : JE2 3RT

Tel: 44 1534 847000

http://www.idhcorp.com/

Registrar Details